SWOG 1609 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

July 10, 2018
https://clinicaltrials.gov/ct2/show/NCT02834013
Cancer - Gastro
Principal Investigator: Ding Wang, MD
CANCER, UNDIFFERENTIATED, EPITHELIAL, RARE, FIBROMIXOMA, MUCINOUS, ACINAR, SEROUS, CHOLANGIOCARCINOMA, SARCOMATOID, GERM CELL, MULLERIAN, CHORIOCARCINOMA, SPINDLE CELL, METAPLASTIC, STROMAL, CHORDOMA, GIANT CELL, DESMOID, PARAGANGLIOMA, PHEOCHROMOCYTOMA
Open